ZSQR · Z Squared Inc.

NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD

Z Squared Inc (Delaware) (ZSQR)

NASDAQ NMS - GLOBAL MARKET Biotechnology
Move probability → Options chain →
$3.58 -0.13 (-3.50%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE $3.58
$3.52 $3.75
52-WEEK RANGE $3.58
$2.11 $18.80

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$275.3M
P/E (TTM1)—
EPS2 (TTM)$-1.79
Div Yield—
Beta3—
Volume26,308
Open3.71
Prev Close3.71
Bid / Ask3.07 / 0.00
Next Earnings 2026-11-11

Analyst Recommendations

Strong buy 0 Buy 0 Hold 3 Sell 1 Strong sell 2

Aggregate ratings for 2025-02-01 (6 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
ZSQR -75.72%
vs S&P 500 -83.26%
3-MONTH RETURN
ZSQR -30.77%

Valuation Measures & Ratios

Enterprise Value4$187.3M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)72.52
Price / Book74.21
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin-785.07%
Operating Margin-787.18%
Return on Equity (ROE8)-50.59%
Return on Assets (ROA9)-47.57%
Avg Volume (3M)537,600
Quarterly history (5 periods)
Measure Jun '26Mar '26Sep '25Jun '25Mar '25
Market cap $521.0M $517 $85.6M — $9.9M
P/E -31.21 -0.00 -10.51 — -0.88
Price/Sales 269.29 0.00 285.08 — 157.29
Price/Book 3.93 0.00 8.26 — 1.53
EV/Revenue 261.28 0.36 285.58 — 157.29
EV/EBITDA -27.42 -0.02 -11.37 — —
ROE -12.60% -36.79% -78.61% — -174.21%
ROA -12.41% -31.94% -57.46% — -83.90%

Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).

Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short4,536,025
Change from Prior Settlement+10.29%
% of Float—
Days to Cover (Short Ratio)9.45

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Jun '26Mar '26Sep '25Jun '25Mar '25Sep '24Jun '24Mar '24
Revenue $1.6M $113.8K $237.4K $0 $62.9K $0 $0 $0
Gross profit -$1.8M $68.6K $192.3K $0 $17.7K $0 $0 $0
Operating income -$13.8M -$3.9M -$2.5M $0 -$4.1M -$2.1M -$2.8M -$2.9M
Net income -$13.8M -$30 -$2.9M $0 -$3.4M -$1.8M -$3.0M -$3.0M
EPS (diluted) $-0.28 $-0.65 $-0.58 $0.00 $-1.10 $-0.05 $-0.08 $-0.08
EPS (basic) $-0.28 $-0.65 $-0.58 $0.00 $-1.10 $-0.05 $-0.08 $-0.08

Balance sheet

Line item Jun '26Apr '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Total assets $134.5M — $19.8M $1.4K $14.2M $12.2M $13.5M $8.9M
Total liabilities $2.0M — $2.2M $120 $3.3M $5.1M $6.0M $5.0M
Stockholders' equity $132.5M — $17.2M $1.3K $10.4M $6.1M $6.5M $3.4M
Total current assets $15.5M — $5.9M $1.4K $6.0M $3.7M $4.7M $1.1M
Total current liabilities $2.0M — $1.8M $120 $2.7M $4.5M $5.7M $4.5M
Cash & equivalents $15.5M — — $1.4K — — — —

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow $1.6M -$1.8M -$1.7M -$6.9M $2.4M -$2.4M -$1.4M -$1.9M
Investing cash flow -$591.5K $591.5K $0 $0 $0 $0 $100.0K $0
Financing cash flow $15.0M $704.3K $2.5M $11.3M -$6.1M $6.1M $732.0K $1.5M
Capital expenditures — — — — — — — —
Depreciation & amortization $862.2K $295.3K $295.3K $885.9K -$295.3K $295.3K $250.2K $250.2K
Share-based compensation $6.0M $1.1M — — — — $1.0M $96.9K

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding ZSQR as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-11 to 2026-09-27

Recent transactions

  • Insiders have net bought 1,000 shares over the last 182 days, across 1 purchase and 0 sales.
  • Most recent: Sohn Adam Craig (Director) — Option exercise of 274 shares on 2026-09-27.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)1,000 sh(1 txns)
Sales (open market)0 sh(0 txns)
Net Shares+1,000

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Sohn Adam CraigDirectorOption exercise2026-09-27274
Fuerst Bryan EricDirectorOption exercise2026-09-27274
Cooper Kenneth LyleDirectorOption exercise2026-09-27274
Harris Jeffery KeeslarChief Technology OfficerOption exercise2026-09-2412,444
Schadel Christopher RyanChief Marketing OfficerOpen market purchase2026-08-181,000
Halabu David EliasChief Executive OfficerOption exercise2026-07-2719,737
Cogley BrianChief Financial OfficerOption exercise2026-07-274,112
BSG Series CM, LLC10% ownerOther acquisition/disposition2026-04-3041,521,276
Burke Michelle EllenCo-Chief Executive OfficerGrant / award2026-04-2716,447
Deschamps PhilippeDirectorOption exercise2026-02-115,700
Calise ChrisDirectorOption exercise2026-02-115,700
Mehalick DavidCEO and PresidentOption exercise2026-02-11148,875
Cochran Christopher P.DirectorOption exercise2026-02-115,700
Yerace Daniel AlexanderVP OperationsOption exercise2026-02-1110,000
Salkind GeneDirectorOption exercise2026-02-115,700

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-09-27Sohn Adam CraigDirectorOption exercise 274$0.00
2026-09-27Fuerst Bryan EricDirectorOption exercise 274$0.00
2026-09-27Cooper Kenneth LyleDirectorOption exercise 274$0.00
2026-09-24Harris Jeffery KeeslarChief Technology OfficerOption exercise 12,444$0.00
2026-08-27Sohn Adam CraigDirectorOption exercise 274$0.00
2026-08-27Fuerst Bryan EricDirectorOption exercise 274$0.00
2026-08-27Cooper Kenneth LyleDirectorOption exercise 274$0.00
2026-08-18Schadel Christopher RyanChief Marketing OfficerOpen market purchase 1,000$3.92
2026-07-27Halabu David EliasChief Executive OfficerOption exercise 19,737$0.00
2026-07-27Sohn Adam CraigDirectorOption exercise 274$0.00
2026-07-27Fuerst Bryan EricDirectorOption exercise 274$0.00
2026-07-27Cooper Kenneth LyleDirectorOption exercise 274$0.00
2026-07-27Cogley BrianChief Financial OfficerOption exercise 4,112$0.00
2026-06-27Sohn Adam CraigDirectorOption exercise 274$0.00
2026-06-27Fuerst Bryan EricDirectorOption exercise 274$0.00
2026-06-27Cooper Kenneth LyleDirectorOption exercise 274$0.00
2026-05-27Sohn Adam CraigDirectorOption exercise 274$0.00
2026-05-27Fuerst Bryan EricDirectorOption exercise 274$0.00
2026-05-27Cooper Kenneth LyleDirectorOption exercise 274$0.00
2026-04-30BSG Series CM, LLC10% ownerOther acquisition/disposition 41,521,276$0.00
2026-04-27Burke Michelle EllenCo-Chief Executive OfficerGrant / award 16,447$0.00
2026-02-11Cogley BrianChief Financial OfficerOption exercise 10,000$10.56
2026-02-11Cogley BrianChief Financial OfficerGrant / award 12,500$0.00
2026-02-11Deschamps PhilippeDirectorOption exercise 5,700$10.56
2026-02-11Deschamps PhilippeDirectorGrant / award 3,250$0.00
2026-02-11Calise ChrisDirectorOption exercise 5,700$10.56
2026-02-11Calise ChrisDirectorGrant / award 3,250$0.00
2026-02-11Mehalick DavidCEO and PresidentOption exercise 148,875$7.05
2026-02-11Mehalick DavidCEO and PresidentGrant / award 51,250$0.00
2026-02-11Cochran Christopher P.DirectorOption exercise 5,700$10.56
2026-02-11Cochran Christopher P.DirectorGrant / award 3,250$0.00
2026-02-11Yerace Daniel AlexanderVP OperationsOption exercise 10,000$10.41
2026-02-11Yerace Daniel AlexanderVP OperationsGrant / award 20,000$0.00
2026-02-11Salkind GeneDirectorOption exercise 5,700$10.56
2026-02-11Salkind GeneDirectorGrant / award 3,250$0.00

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-22 07:11 UTC

FiledFormReport periodOfficial filing
2026-10-0542026-10-02 View on SEC.gov →
2026-10-0242026-04-27 View on SEC.gov →
2026-10-0242026-05-27 View on SEC.gov →
2026-10-0242026-05-27 View on SEC.gov →
2026-10-0242026-05-27 View on SEC.gov →
2026-10-0242026-09-24 View on SEC.gov →
2026-10-0242026-07-27 View on SEC.gov →
2026-09-148-K2026-09-08 View on SEC.gov →
2026-09-108-K2026-09-09 View on SEC.gov →
2026-08-268-K2026-08-24 View on SEC.gov →
2026-08-2542026-08-24 View on SEC.gov →
2026-08-2042026-08-18 View on SEC.gov →

Headlines about ZSQR (Z Squared Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist